Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised Double-Blind Placebo Controlled Trial of Atorvastatin in Ward Patients with Sepsis
2005-004636-52Phase 2Unknown
- Sponsor
- Heart of England NHS Foundation Trust
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in sepsis comparing Atorvastatin 40 mg/day with Placebo (2 arms). Primary endpoint: Progression from sepsis to severe sepsis. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
sepsis
Beyond the preview
Go deeper on 2005-004636-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004636-52.